Substances used in completed suicide by overdose in Toronto: An observational study of coroner's data

Canadian Journal of Psychiatry

Volumn 57, Issue 3, 2012, Pages 184-191

  Sinyor, Mark ^a   Howlett, Andrew ^a   Cheung, Amy H ^a   Schaffer, Ayal ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antidepressant; Opioid; Over thecounter medication; Overdose; Suicide; Toronto

Indexed keywords

ALCOHOL; AMFEBUTAMONE; AMITRIPTYLINE; ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; ANXIOLYTIC AGENT; CITALOPRAM; DILTIAZEM; DIPHENHYDRAMINE; FLUVOXAMINE; HYPNOTIC SEDATIVE AGENT; ILLICIT DRUG; MIRTAZAPINE; MOOD STABILIZER; NON PRESCRIPTION DRUG; OPIATE; PAROXETINE; PRESCRIPTION DRUG; PSYCHOTROPIC AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE;

ADULT; AGE DISTRIBUTION; ALCOHOL ABUSE; ALCOHOL INTOXICATION; ARTICLE; CANADA; CAUSE OF DEATH; CORONER; DRUG INTOXICATION; DRUG OVERDOSE; FEMALE; HUMAN; LETHAL DOSE; LETHALITY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; MULTIPLE DRUG ABUSE; OBSERVATIONAL STUDY; SEX RATIO; SUICIDE;

EID: 84868670058     PISSN: 07067437     EISSN: 14970015     Source Type: Journal    
DOI: 10.1177/070674371205700308     Document Type: Article

References (28)

1. Statistics Canada. Leading causes of death, by sex [Internet]. Ottawa (ON): Statistics Canada; 2010 [cited 2010 Oct 26]. Available from: http://www40.statcan.ca/101/cst01/hlth36a-eng.htm.
2. Centers for Disease Control and Prevention. Twenty leading causes of death highlighting suicide among persons ages 10 years and older, United States, 2006 [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; 2009 [cited 2010 Oct 26]. Available from: http://www.cdc.gov/violenceprevention/ suicide/statistics/leading-causes.html.
3. Karch D, Dhalberg, L, Patel N. Surveilance for violent deaths - National Violent Death Reporting System, 16 States, 2007. MMWR Surveill Summ. 2010;59(4):1-50.
4. Centers for Disease Control and Prevention. Toxicology testing and results for suicide victims - 13 states, 2004. MMWR Morb Mortal Wkly Rep. 2006;55(46);1245-1248.
5. Shields LBE, Hunsaker DM, Hunsaker III JC, et al. Toxicologic findings in suicide: a 10-year retrospective review of Kentucky medical examiner cases. Am J Forensic Med Pathol. 2006;27(2):106-112.
6. Buckley NA, Whyte IM, Dawson AH, et al. Self-poisoning in Newcastle, 1987-1992. Med J Aust. 1995;162(4):190-193.
7. Poulin C, Stein J, Butt J. Surveillance of drug overdose deaths using medical examiner data [Internet]. Chron Dis Can. 2000;19(4) [cited 2010 Sep 29]. Available from: http://www.phac-aspc.gc.ca/publicat/cdic-mcc/19-4/f-e.html.
8. Dhossche DM. Toxicology of suicide: touchstone for suicide prevention? Med Sci Monit. 2003;9(4):SR9-SR19.
9. Sinyor M, Levitt AJ. Effect of a barrier at Bloor street viaduct on suicide rates in Toronto: natural experiment. BMJ. 2010;341:C2884.
10. Statistics Canada. Population and dwelling counts for Toronto and Ontario [Internet]. Ottawa (ON): Statistics Canada; 2010 [cited 2011 May 26]. Available from: http://www12.statcan.ca/census-recensement/2006/dp-pd/prof/92-591/ details/page.cfm?Lang=E&Ge01=CSD&Code1=3520005&Ge02=PR&Code2= 35&Data=Count&SearchText=toronto&SearchType=Begins&SearchPR= 01&B1=All&Custom.
11. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300(22):2613-2620.
12. National Opioid Use Guideline Group (NOUGG). Canadian guideline for safe and effective use of opioids for chronic non-cancer pain - Part B: recommendations for practice, version 5.5. Hamilton (ON): National Pain Centre; 2010 [cited 2010 Sep 29]. p 57. Available from: http://nationalpaincentre. mcmaster.ca/opioid.
13. Hawton K, Bergen H, Simkin S, et al. Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose. Br J Psychiatry. 2010;196(5):354-358.
14. US Food and Drug Administration. FDA drug safety communication: abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide). Silver Springs (MD): US Food and Drug Administration; 2011 [cited 2011 Oct 20]. Available from: http://www.fda.gov/Drugs/DrugSafety/ucm269086.htm.
15. Isacsson G, Holmgren P, Druid H, et al. Psychotropics and suicide prevention. Implications from toxicological screening of 5281 suicides in Sweden 1992-1994. Br J Psychiatry. 1999;174:259-265.
16. Pragst F, Herre S, Bakdash A. Poisonings with diphenhydramine - a survey of 68 clinical and 55 death cases. Forensic Sci Int. 2006;161(2-3):189-197.
17. Gunnell D, Murray V, Hawton K. Use of paracetamol (acetaminophen) for suicide and nonfatal poisoning: worldwide patterns of use and misuse. Suicide Life Threat Behav. 2000;30(4):313-326.
18. Hawton K. United Kingdom legislation on pack sizes of analgesics: background, rationale, and effects on suicide and deliberate self-harm. Suicide Life Threat Behav. 2002;32(3):223-229.
19. Hawton K, Townsend E, Deeks J, et al. Effects of legislation restricting pack sizes of paracetamol and salicylate on self-poisoning in the United Kingdom: before and after study. BMJ. 2001;322(7296):1203-1207.
20. Hawkins LC, Edwards JN, Dargan PI. Impact of restricting paracetamol pack sizes on paracetamol poisoning in the United Kingdom: a review of the literature. Drug Saf. 2007;30(6):465-479.
21. Bateman DN. Limiting paracetamol pack size: has it worked in the UK? Clin Toxicol. 2009;47(6):536-541.
22. Proano L, Chiang WK, Wang RY. Calcium channel blocker overdose. Am J Emerg Med. 1995;13(4):444-450.
23. Roper TA, Sykes R, Gray C. Fatal diltiazem overdose: report of four cases and review of the literature. Postgrad Med J. 1993;69(812):474-476.
24. Keller S, Frishman WH. Neuropsychiatric effects of cardiovascular drug therapy. Cardiol Rev. 2003;11(2):73-93.
25. Phillips JA, Robin AV, Nugent CN, et al. Understanding recent changes in suicide rates among the middle-aged: period or cohort effects? Public Health Rep. 2010;125(5):680-688.
26. Centers for Disease Control and Prevention. Increases in age-group - specific injury mortality - United States, 1999-2004. MMWR Morb Mortal Wkly Rep. 2007;56(49):1281-1284.
27. Bolton JM, Pagura J, Enns MW, et al. A population-based longitudinal study of risk factors for suicide attempts in major depressive disorder. J Psychiatr Res. 2010;44(13):817-826.
28. Sareen J, Cox BJ, Afifi TO, et al. Anxiety disorders and risk for suicidal ideation and suicide attempts: a populationbased longitudinal study of adults. Arch Gen Psychiatry. 2005;62(11):1249-1257.